Average Co-Inventor Count = 7.49
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (14 from 1,384 patents)
2. Bayer Pharma Aktiengesellschaft (3 from 378 patents)
3. Bayer Schering Pharma Ag (3 from 192 patents)
4. Celtaxsys, Inc. (2 from 15 patents)
5. Shering Ag (1 from 7 patents)
6. Celltaxis, LLC (1 from 4 patents)
7. Bayer Pharma Aktiengessellschaft (1 from 2 patents)
8. Estrellita Pharmaceuticals, LLC (1 from 1 patent)
9. Celltaxsis, LLC (1 from 1 patent)
10. Schring Aktiengesellschaft (1 from 1 patent)
11. Bayer Intellectual Property Gmbh (721 patents)
12. Walter Elger (0 patent)
13. Sybille Beier (0 patent)
14. Cornelius Scheidges (0 patent)
15. Gunter Neef (0 patent)
28 patents:
1. 12173009 - Diamine derivatives as inhibitors of leukotriene Ahydrolase
2. 11524938 - Aromatic sulfonamide derivatives
3. 11267819 - Diamine derivatives as inhibitors of leukotriene A4 hydrolase
4. 10844016 - Aromatic sulfonamide derivatives
5. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors
6. 9890147 - 2,3-benzodiazepines
7. 9315509 - Diamine derivatives as inhibitors of leukotriene A4 hydrolase
8. 8569303 - Diamine derivatives as inhibitors of leukotriene A4 hydrolase
9. 8053426 - Progesterone receptor antagonists
10. 7910573 - Crystalline forms of 11β-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-one
11. 7737145 - [object Object]
12. 7601748 - Anti-androgenic pyrrolidines with tumor-inhibiting action
13. 7148213 - Antigestagenically active steroids with a fluorinated 17α-alkyl chain
14. 7138421 - Anti-androgenic pyrrolidines with tumor-inhibiting action
15. 6861432 - Piperazine derivatives that destabilize androgen receptors